Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

Q: What does CUSIP 15673T100 represent in this 13F holders report?

CUSIP 15673T100 is the security identifier for IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2021?

50 institutional investors reported IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 15673T100

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 87,670,044
Total 13F shares: 21,137,514
Share change: +1,629,481
Total reported value: $335,200,000
Price per share: $15.86
Number of holders: 50
Value change: +$24,348,825
Number of buys: 29
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 15673T100?
CUSIP 15673T100 identifies IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 15673T100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	9.3%	8,160,584	$203,390,000	—	30 Sep 2021	13F
Casdin Capital, LLC	13F	Company	3.7%	3,206,380	$80,673,000	—	30 Sep 2021	13F
FEDERATED HERMES, INC.	13F	Company	1.3%	1,164,094	$29,289,000	—	30 Sep 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1%	914,094	$22,999,000	—	30 Sep 2021	13F
BAYER AKTIENGESELLSCHAFT	3/4/5	10%+ Owner	— class O/S missing	12,675,838	$18,886,999	—	22 Jun 2021	3/4/5
Avidity Partners Management LP	13F	Company	0.84%	739,269	$18,600,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	0.74%	648,656	$16,320,000	—	30 Sep 2021	13F
Logos Global Management LP	13F	Company	0.73%	639,095	$16,080,000	—	30 Sep 2021	13F
HHLR ADVISORS, LTD.	13F	Company	0.7%	614,095	$15,451,000	—	30 Sep 2021	13F
Octagon Capital Advisors LP	13F	Company	0.69%	602,623	$15,162,000	—	30 Sep 2021	13F
Marshall Wace North America L.P.	13F	Company	0.65%	571,053	$14,367,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	0.5%	434,610	$10,935,000	—	30 Sep 2021	13F
FUJIFILM Cellular Dynamics, Inc.	3/4/5	10%+ Owner	— class O/S missing	6,955,207	$10,363,258	—	22 Jun 2021	3/4/5
ORBIMED ADVISORS LLC	13F	Company	0.46%	407,047	$10,241,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.38%	331,862	$8,351,000	—	30 Sep 2021	13F
Woodline Partners LP	13F	Company	0.29%	250,094	$6,292,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.23%	204,691	$5,150,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	0.17%	148,762	$3,743,000	—	30 Sep 2021	13F
MARSHALL WACE, LLP	13F	Company	0.13%	111,552	$2,807,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.12%	103,788	$2,611,000	—	30 Sep 2021	13F
DAFNA Capital Management LLC	13F	Company	0.09%	80,000	$2,013,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	75,076	$1,889,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.08%	69,024	$1,737,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.07%	63,424	$1,596,000	—	30 Sep 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.03%	30,000	$755,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.03%	28,932	$727,000	—	30 Sep 2021	13F
Parametrica Management Ltd	13F	Company	0.03%	28,755	$723,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	27,783	$699,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	24,044	$605,000	—	30 Sep 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.02%	20,856	$525,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	16,701	$420,000	—	30 Sep 2021	13F
Ghisallo Capital Management LLC	13F	Company	0.02%	15,000	$377,000	—	30 Sep 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	13,600	$342,000	—	30 Sep 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	8,697	$219,000	—	30 Sep 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	6,795	$171,000	—	30 Sep 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	6,463	$163,000	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	6,381	$161,000	—	30 Sep 2021	13F
SG Americas Securities, LLC	13F	Company	0.01%	5,314	$134,000	—	30 Sep 2021	13F
MetLife Investment Management, LLC	13F	Company	0.01%	4,939	$124,265	—	30 Sep 2021	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0%	3,737	$94,023	—	30 Sep 2021	13F
STRS OHIO	13F	Company	0%	2,700	$67,000	—	30 Sep 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0%	2,100	$53,000	—	30 Sep 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,399	$35,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0%	1,335	$34,000	—	30 Sep 2021	13F
Legal & General Group Plc	13F	Company	0%	1,105	$28,000	—	30 Sep 2021	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	905	$23,000	—	30 Sep 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	597	$15,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0%	482	$12,000	—	30 Sep 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	200	$5,000	—	30 Sep 2021	13F
Patriot Financial Group Insurance Agency, LLC	13F	Company	0%	65	$2,000	—	30 Sep 2021	13F

Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q4 2021

As of 31 Dec 2021, Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,137,514 shares. The largest 10 holders included FMR LLC, Casdin Capital, LLC, FEDERATED HERMES, INC., RA CAPITAL MANAGEMENT, L.P., Avidity Partners Management LP, BlackRock Inc., Octagon Capital Advisors LP, MARSHALL WACE, LLP, Logos Global Management LP, and HHLR ADVISORS, LTD.. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.